About Marker Therapeutics
Investors/Media
SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Mar 18, 2022
Document Date
Mar 18, 2022
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Marker Therapeutics, Inc.
Issuer
MARKER THERAPEUTICS, INC.